Fulcrum Therapeutics
FULC
#6790
Rank
A$0.90 B
Marketcap
A$13.68
Share price
-3.54%
Change (1 day)
119.96%
Change (1 year)

EPS for Fulcrum Therapeutics (FULC)

EPS in 2025 (TTM): A-$1.84

According to Fulcrum Therapeutics's latest financial reports the company's current EPS (TTM) is A-$1.69. In 2024 the company made an earnings per share (EPS) of A-$0.29 an increase over its 2023 EPS that were of A-$2.26.

EPS history for Fulcrum Therapeutics from 2019 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$1.84542.65%
2024A-$0.29-87.34%
2023A-$2.26-36.29%
2022A-$3.558.3%
2021A-$3.28-18.51%
2020A-$4.03-31.36%
2019A-$5.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.48 46.61%๐Ÿ‡บ๐Ÿ‡ธ USA